UC San Diego and Genentech scientists develop potentially disruptive antibody sequencing technology

Bioinformatics researchers at the University of California, San Diego and Genentech have developed a new, quicker way to sequence monoclonal antibodies – a process that is many times faster than the sequencing technology typically used by academic and industry researchers today.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news148907050.html">UC San Diego and Genentech scientists develop potentially disruptive antibody sequencing technology</a></p> <p>Bioinformatics researchers at the University of California, San Diego and Genentech have developed a new, quicker way to sequence monoclonal antibodies – a process that is many times faster than the sequencing technology typically used by academic and industry researchers today.</p>